ORDER OF THE GOVERNMENT OF THE KYRGYZ REPUBLIC

of July 8, 2014 No. 376

About approval of the Program of the Government of the Kyrgyz Republic for development of the sphere of drug circulation in the Kyrgyz Republic for 2014-2020

For the purpose of implementation of the Law of the Kyrgyz Republic "About medicines", further enhancement of the pharmaceutical sector, according to articles 10 and 17 of the constitutional Law of the Kyrgyz Republic "About the Government of the Kyrgyz Republic" the Government of the Kyrgyz Republic decides:

1. Approve enclosed:

- The program of the Government of the Kyrgyz Republic for development of the sphere of drug circulation in the Kyrgyz Republic for 2014-2020;

- The actions plan on program implementation of the Government of the Kyrgyz Republic on development of the sphere of drug circulation in the Kyrgyz Republic for 2014-2020.

2. To the Ministry of Health of the Kyrgyz Republic to perform general coordination of program implementation of the Government of the Kyrgyz Republic on development of the sphere of drug circulation in the Kyrgyz Republic for 2014-2020 and the Actions plan on its realization.

3. Declare invalid the order of the Government of the Kyrgyz Republic "About the State medicinal policy of the Kyrgyz Republic for 2007-2010" of January 12, 2007 No. 11.

4. This resolution becomes effective from the date of official publication.

5. To impose control of execution of this resolution on department of education, culture and sport of Government office of the Kyrgyz Republic.

Approved by the Order of the Government of the Kyrgyz Republic of July 8, 2014 No. 376

The program of the Government of the Kyrgyz Republic for development of the sphere of drug circulation in the Kyrgyz Republic for 2014-2020

Introduction

The constitution of the Kyrgyz Republic declares the right of each citizen to health protection. Ensuring access to drugs as integral part of public health care is one of the most important tasks of the state. Harmonious development of the pharmaceutical sector has important social and economic value for Kyrgyzstan.

The program of the Government of the Kyrgyz Republic for development of the sphere of drug circulation in the Kyrgyz Republic for 2014-2020 (further - the Program) determines the principles, the purposes, tasks and priorities delivered by the Government of the Kyrgyz Republic in the field of drug circulation applied to prevention, diagnostics and treatments of the person. For the period realization three state medicinal politician are marked out significant progress in the field of the medicinal address. With acceptance of the first state medicinal policy in 1998 in the republic the institutional base on management behind drug circulation (further - HP) and products of medical appointment (further - IMN), foundation of the most regulatory body, and establishment of procedures and mechanisms of regulation (registration, certification, licensing, control and analytical service, inspection) including both was created. Within realization state medicinal the politician was carried out the corresponding work on review of the legislation regulating the relations in the field of the address of HP and IMN. For the purpose of expense reduction of the population the measures providing preferential provision of medicines, promotion of proper practice of prescription of medicines and their rational use were implemented: provision of medicines within the Program of the state guarantees for providing citizens of the Kyrgyz Republic with the medical and sanitary help (further - LO PGG), the Additional program of compulsory medical insurance for provision of medicines at the out-patient level (further - DP compulsory health insurance), selection of HP for inclusion in the List of the vital medicines (further - PZhVLS), development of the Form of the main HP, development of clinical managements and clinical protocols (further - KR/KP). Within preferential medicinal programs the procedure for prescription dispensing and prescription of HP under generic names is implemented.

The foundation for ensuring geographical and physical availability of HP was laid, the network of pharmaceutical institutions, including in villages considerably extended.

The principles of evidential medicine and rational use of medicines are integrated into training programs of medical education. Implementation of information technologies at the level of Department of provision of medicines and medical equipment (further - DLO and MT), Fund of compulsory medical insurance is begun under the Government of the Kyrgyz Republic (further - Federal Compulsory Health Insurance Fund) and the organizations of health care.

Despite the available achievements, in Kyrgyzstan there is number of problems. The sharpest of them is the growing financial burden of the population which is directly connected with expenses on HP and causing restrictions in their availability. Unethical marketing practice from outside pharmaceutical the companies, including active advertizing HP in mass media, promotes further increase in prices for HP, overconsumption of HP among the population, both on medical appointment, and as a result of self-treatment. Need of further enhancement of the processes of registration connected with safety, efficiency and quality of HP, promotion of the principles of rational use of HP in practical health care remains. Weakness of institutional capacity of governing bodies of the sphere of the medicinal address along with continuous checks of regulatory body the weak interdepartmental cooperation and availability of legal collisions in the legislation cause insufficient coordination and transparency of activities in the field.

The program and the Actions plan for its realization will promote goal achievement of the National program of reforming of the health care system "Dan Sooluk" approved by the order of the Government of the Kyrgyz Republic of May 24, 2012 No. 309, regarding improvement of indicators of health of the population in the priority directions and qualities of rendering key individual services.

Chapter 1. Purpose and tasks of the Program

The purpose of the Program is ensuring availability of the vital, safe, effective and high-quality HP to citizens of the Kyrgyz Republic and their rational use.

Tasks of the Program are:

1) ensuring economic availability of the main HP and IMN;

2) ensuring presence in the market of the safe, effective and high-quality generics having equal original HP clinical efficiency;

3) increase in responsibility and role of the Ministry of Health of the Kyrgyz Republic (further - the Ministry of Health) in coordination of medicinal policy and optimization of management structure the address of HP;

4) recognition of HP special type of products exerting impact on human health which quality and efficiency objectively can not always estimate the doctor appointing HP the patient;

5) ensuring efficiency and transparency of purchases of HP and IMN in all organizations of health care;

6) development of effective price policy;

7) development of measures of counteraction to unethical marketing of HP and IMN;

8) ensuring availability to the population of the HP included in PZhVLS;

9) step-by-step implementation of rules proper the practician in the field of drug circulation;

10) ensuring effective and timely post-marketing control of safety, efficiency and quality of drugs;

11) ensuring coordination of activities of the interested government institutions in fight against the illegal market of HP and IMN;

12) ensuring transparency in the field of the medicinal address and regulation of the address of HP and IMN through creation of unified information system;

13) strengthening of personnel potential in the field of the address of HP.

The program implementation will be based on the following principles:

1) succession of reform policy of health care;

2) focus on ensuring justice in access to the vital HP, especially for vulnerable segments of the population;

3) further support of policy of usage of generic HP;

4) focus of the sphere of the medicinal address on respect for ethical standards;

5) transparency at all stages of process of the medicinal address;

6) broad involvement of all concerned parties in process of forming, realization, assessment of policy and feedback in the field of HP.

Chapter 2. Ensuring economic availability of medicines and products of medical appointment

§ 1. Approaches to improvement of economic availability of medicines

One of important results of this Program improvement of economic availability of HP through enhancement of the existing procedures and the practician of purchases for realization of internal reserves of economy and rationalization of the costs influencing demand for HP and also through implementation of new approaches of the state influence on their prices is expected.

Regulation of demand for HP is offered to be performed through:

- implementation of effective strategy of selection of the main HP and increase in demand for cheaper generic HP, when ensuring equal clinical efficiency;

- rationalization of practice of consumption of HP;

- enhancement of the program of preferential provision of medicines of citizens;

- optimization of system of public procurements of HP.

The system of the state influence on the prices will be determined by availability of the weighed price policy of the state concerning pharmaceutical products for ensuring reasonable prices for the population for drugs, in particular from PZhVLS.

§ 2. System of selection of medicines

For the purpose of expense reduction on inefficient types of the medicinal help and concentration of efforts on provision of equal access for citizens to the most effective and safe evidence-based HP within the available resources, the Government of the Kyrgyz Republic the List of the vital medicines, taking into account recommendations of the World Health Organization periodically affirms (further - WHO).

Disclaimer! This text was translated by AI translator and is not a valid juridical document. No warranty. No claim. More info